CDKN2A and glioblastoma: Targeted DNA sequencing revealed EGFR alteration was mutually exclusive with NF1 mutation, as previously reported (1–3), and showed an association of CDKN2A/B homozygous deletion with worse OS in NF1-mutant, but not NF1 wild-type, glioblastoma.